How should I evaluate and manage a patient with one month of amenorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of One Month of Amenorrhea

For a patient with only one month of amenorrhea, first rule out pregnancy with a urine or serum β-hCG test, then provide reassurance that a single missed period does not require extensive workup or treatment in most cases.

Initial Assessment

Pregnancy Testing

  • Perform a pregnancy test immediately in all women of reproductive age presenting with amenorrhea, regardless of contraceptive use or sexual history 1, 2, 3.
  • This is the single most important initial step, as pregnancy is the most common cause of secondary amenorrhea 2, 3.

Clinical Context Matters

One month of amenorrhea does not meet diagnostic criteria for secondary amenorrhea, which requires cessation of regular menses for three months or irregular menses for six months 2, 3.

However, certain clinical scenarios warrant earlier evaluation:

  • Abrupt change from regular cycles to amenorrhea in a woman using hormonal contraception (implant, DMPA, combined hormonal contraceptives) may warrant pregnancy testing if clinically indicated 1.
  • New medications that could affect menstruation, particularly antiepileptic drugs (valproate, carbamazepine, phenobarbital, phenytoin) which can cause menstrual disturbances 1.
  • Significant weight changes, eating disorder behaviors, or excessive exercise patterns 2, 4.
  • Symptoms suggesting underlying pathology: galactorrhea, hirsutism, hot flashes, headaches, or visual changes 2, 3.

Management Approach

For Contraceptive-Related Amenorrhea

If the patient is using hormonal contraception:

  • Provide reassurance that amenorrhea with contraceptive implants, DMPA, or extended-cycle combined hormonal contraceptives is common and not harmful 1.
  • No medical treatment is required for contraceptive-induced amenorrhea 1.
  • Approximately 22% of implant users experience amenorrhea, and it increases to common occurrence after ≥1 year of DMPA use 1.

For Non-Contraceptive Amenorrhea

Observation is appropriate for one month of amenorrhea in an otherwise healthy woman with:

  • Negative pregnancy test
  • No concerning symptoms
  • No significant recent stressors, weight changes, or medication changes
  • Previously regular cycles

Counsel the patient to return if:

  • Amenorrhea persists for three months (if previously regular cycles) 2, 3
  • New symptoms develop (galactorrhea, hirsutism, vasomotor symptoms) 2
  • She desires pregnancy and cycles do not resume 2

When to Pursue Earlier Workup

Consider laboratory evaluation before three months if:

  • High clinical suspicion for specific pathology: symptoms of hyperprolactinemia, thyroid disease, or hyperandrogenism 2, 3
  • Patient on antiepileptic drugs: these medications can cause functional hyperprolactinemia, PCOS, hypothalamic amenorrhea, or premature ovarian failure 1
  • Significant psychosocial stressors or eating disorder concerns: functional hypothalamic amenorrhea affects 12% of women with temporal lobe epilepsy but only 1.5% of the general population, suggesting stress-related mechanisms 1, 4

Initial Laboratory Panel (if indicated)

  • Serum β-hCG (pregnancy test)
  • Thyroid-stimulating hormone (TSH)
  • Prolactin
  • Follicle-stimulating hormone (FSH)
  • Luteinizing hormone (LH)

2, 3, 5

Common Pitfalls to Avoid

  • Do not initiate extensive hormonal workup for a single missed period in an asymptomatic woman with negative pregnancy test 2, 3.
  • Do not assume infertility: even women with primary ovarian insufficiency can maintain unpredictable ovarian function 6, 3.
  • Do not overlook medication effects: particularly antiepileptic drugs, which have multiple mechanisms for causing amenorrhea including effects on the hypothalamic-pituitary axis, peripheral endocrine glands, and hormone metabolism 1.
  • Do not dismiss patient concern: while reassurance is appropriate, validate concerns and establish clear follow-up parameters 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amenorrhea: an approach to diagnosis and management.

American family physician, 2013

Research

Amenorrhea: evaluation and treatment.

American family physician, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.